GLP-1 weight-loss drugs like Ozempic and Wegovy may help reduce alcohol cravings and heavy drinking, offering promising ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

Muscimol, a GABA-A (GABAA) receptor agonist, enhances GABA's inhibitory effect on neuronal activity by activating GABAA ...

Glucagon-like peptide 1 receptor agonist treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms.

Currently available therapeutic strategies for alcohol use disorder (AUD) have limited efficacy, with many patients not responding to treatment. The dopaminergic system, involved in motivation and the ...

This important study investigated whether the nuclear receptor Nur77 is regulated by a non-canonical mechanism of ligand-induced disruption of its interaction with RXRg, similar to the family member ...

Chronic alcohol use depletes nutrients—and poor nutrition increases risk for alcohol dependence. Learn how diet, brain ...

Like opioids, SBI-810 works on the nervous system to relieve pain. The experimental compound is designed to target a receptor ...

Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...

Oda herbal products, such as evening primrose oil, soya, red clover, black cohosh, and ginseng, dey commonly used to reduce ...

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

Dopamine deficiency occurs when levels of the neurotransmitter dopamine are low, affecting movement, emotions, sleep, and ...